2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (2203):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-43656
    Methyl 2-amino-4-morpholinobenzoate
    Methyl 2-amino-4-morpholinobenzoate is a drug intermediate for synthesis of various active compounds.
    Methyl 2-amino-4-morpholinobenzoate
  • HY-I1119
    Dapagliflozin impurity 111
    Dapagliflozin impurity 111 is an impurity of Dapagliflozin (HY-10450).
    Dapagliflozin impurity 111
  • HY-134760
    Vitamin impurity 3
    Vitamin impurity 3 is an impurity of Vitamin.
    Vitamin impurity 3
  • HY-23269
    5-(M-Tolyl)tetrazole
    5-(M-Tolyl)tetrazole is a drug intermediate for synthesis of various active compounds.
    5-(M-Tolyl)tetrazole
  • HY-41004
    3-Isoquinolinecarboxylic acid
    		99.90%
    3-Isoquinolinecarboxylic acid (compound 2) is a synthetic intermediate that has been used to design antitumor compounds.
    3-Isoquinolinecarboxylic acid
  • HY-Z1086
    4-Chloro-2-methoxybenzonitrile
    4-Chloro-2-methoxybenzonitrile is a drug impurity.
    4-Chloro-2-methoxybenzonitrile
  • HY-W053519
    DL-Pantolactone
    		98.51%
    DL-Pantolactone is a γ-lactone that can be hydrolyzed to Pantoic acid (HY-W399035) by the lactonohydrolase of Fusarium oxysporum. DL-Pantolactone also can be used in the preparation of 3,5-dinitrobenzoyl-DL-pantolactone.
    DL-Pantolactone
  • HY-Z0381
    Ilurodoline impurity 10
    		99.75%
    Ilurodoline impurity 10 is an impurity of Ilurodoline.
    Ilurodoline impurity 10
  • HY-Z4457
    Arolol impurity 2
    Arolol impurity 2 is a drug impurity.
    Arolol impurity 2
  • HY-Z0446
    BOC-Ile-N(OCH3)CH3
    BOC-Ile-N(OCH3)CH3 is a drug impurity.
    BOC-Ile-N(OCH3)CH3
  • HY-20821
    Uradil impurity 1
    		98.48%
    Uradil impurity 1 is an impurity of Uradil.
    Uradil impurity 1
  • HY-32694
    1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride
    1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride is a drug intermediate for synthesis of various active compounds.
    1-(Piperidin-4-yl)-1H-imidazo[4,5-b]pyridin-2(3H)-one Hydrochloride
  • HY-W002356
    2-Pyridinecarbothioamide
    		99.94%
    2-Pyridinecarbothioamide is a building block, that can be used for synthesis of Zn2+ responsive fluorescent probe.
    2-Pyridinecarbothioamide
  • HY-W033277
    Tetrakis(acetonitrile)palladium(II) tetrafluoroborate
    		≥98.0%
    Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (NSC 307191) acts as a potent Lewis acid and facilitates the formation of the 2:1 complex [Pd(1,2-bis(2′-pyridylethynyl)benzene)2](BF4)2 through the Sonogashira cross-coupling reaction.
    Tetrakis(acetonitrile)palladium(II) tetrafluoroborate
  • HY-75256
    Ramelteon impurity 10
    		98.66%
    Ramelteon impurity 10 is an impurity of Ramelteon (HY-A0014).
    Ramelteon impurity 10
  • HY-48187
    KRAS inhibitor-39
    KRAS inhibitor-39 (Example 46) is an intermediate of BI-0474 (HY-148278). BI-0474 is a robust KRASG12C inhibitor.
    KRAS inhibitor-39
  • HY-W014347
    Methyl 3-methoxy-4-nitrobenzoate
    		99.48%
    Methyl 3-methoxy-4-nitrobenzoate is a drug intermediate for synthesis of various active compounds.
    Methyl 3-methoxy-4-nitrobenzoate
  • HY-W043437
    Isopropyl benzenesulfonate
    		99.61%
    Isopropyl benzenesulfonate (Isopropyl besylate) is a sulfonate ester and a potential genotoxic impurity.
    Isopropyl benzenesulfonate
  • HY-Z4752
    Nintedanib impurity 3
    		99.55%
    Nintedanib impurity 3 is an impurity of Nintedanib (HY-50904).
    Nintedanib impurity 3
  • HY-78975
    2-(Hydroxymethyl)-pyrimidine
    		99.91%
    2-(Hydroxymethyl)-pyrimidine is a synthetic intermediate useful for pharmaceutical synthesis.
    2-(Hydroxymethyl)-pyrimidine